文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

亚洲女性乳腺癌的流行病学和临床病理学与美国人群的对比。

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population.

出版信息

J Natl Cancer Inst. 2019 Dec 1;111(12):1298-1306. doi: 10.1093/jnci/djz090.


DOI:10.1093/jnci/djz090
PMID:31093668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6910158/
Abstract

BACKGROUND: The incidence of breast cancer among younger East Asian women has been increasing rapidly over recent decades. This international collaborative study systemically compared the differences in age-specific incidences and pathological characteristics of breast cancer in East Asian women and women of predominantly European ancestry. METHODS: We excerpted analytic data from six national cancer registries (979 675 cases) and eight hospitals (18 008 cases) in East Asian countries and/or regions and, for comparisons, from the US Surveillance, Epidemiology, and End Results program database. Linear regression analyses of age-specific incidences of female breast cancer and logistic regression analyses of age-specific pathological characteristics of breast cancer were performed. All statistical tests were two-sided. RESULTS: Unlike female colorectal cancer, the age-specific incidences of breast cancer among East Asian women aged 59 years and younger increased disproportionally over recent decades relative to rates in US contemporaries. For years 2010-2014, the estimated age-specific probability of estrogen receptor positivity increased with age in American patients, whereas that of triple-negative breast cancer (TNBC) declined with age. No similar trends were evident in East Asian patients; their probability of estrogen receptor positivity at age 40-49 years was statistically significantly higher (odd ratio [OR] = 1.50, 95% confidence interval [CI] = 1.36 to 1.67, P < .001) and of TNBC was statistically significantly lower (OR = 0.79, 95% CI = 0.71 to 0.88, P < .001), whereas the probability of ER positivity at age 50-59 years was statistically significantly lower (OR = 0.88, 95% CI = 0.828 to 0.95, P < .001). Subgroup analyses of US Surveillance, Epidemiology, and End Results data showed similarly distinct patterns between East Asian American and white American patients. CONCLUSIONS: Contrasting age-specific incidences and pathological characteristics of breast cancer between East Asian and American women, as well as between East Asian Americans and white Americans, suggests racial differences in the biology.

摘要

背景:近几十年来,东亚年轻女性乳腺癌的发病率一直在迅速上升。本项国际合作研究系统地比较了东亚女性与主要为欧洲血统女性乳腺癌在年龄特异性发病率和病理特征方面的差异。

方法:我们从东亚国家和/或地区的 6 个国家癌症登记处(979675 例)和 8 家医院(18008 例)中摘录了分析数据,并与美国监测、流行病学和最终结果计划数据库中的数据进行了比较。对女性乳腺癌年龄特异性发病率进行线性回归分析,对乳腺癌年龄特异性病理特征进行逻辑回归分析。所有统计检验均为双侧检验。

结果:与女性结直肠癌不同,东亚女性年龄在 59 岁及以下的乳腺癌年龄特异性发病率在过去几十年中与美国同期相比不成比例地增加。在 2010-2014 年,美国患者中雌激素受体阳性的年龄特异性概率随年龄增加而增加,而三阴性乳腺癌(TNBC)的概率随年龄下降。东亚患者中没有出现类似的趋势;她们在 40-49 岁时雌激素受体阳性的概率显著更高(比值比 [OR] = 1.50,95%置信区间 [CI] = 1.36 至 1.67,P <.001),TNBC 的概率显著更低(OR = 0.79,95%CI = 0.71 至 0.88,P <.001),而在 50-59 岁时雌激素受体阳性的概率显著更低(OR = 0.88,95%CI = 0.828 至 0.95,P <.001)。对美国监测、流行病学和最终结果数据的亚组分析显示,东亚裔美国人和白种裔美国患者之间也存在类似的明显差异。

结论:东亚和美国女性以及东亚裔美国人和白种裔美国女性乳腺癌在年龄特异性发病率和病理特征方面存在差异,表明生物学上存在种族差异。

相似文献

[1]
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population.

J Natl Cancer Inst. 2019-12-1

[2]
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.

Breast Cancer Res. 2007

[3]
Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.

J Natl Cancer Inst. 2012-7-5

[4]
Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.

JAMA Netw Open. 2020-10-1

[5]
Breast cancer among Asian Indian and Pakistani Americans: A surveillance, epidemiology and end results-based study.

Int J Cancer. 2021-4-1

[6]
Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women.

Cancer Causes Control. 2010-6-18

[7]
Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.

Cancer Epidemiol. 2014-10

[8]
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

J Natl Cancer Inst. 2005-7-6

[9]
Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.

Front Public Health. 2022

[10]
Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.

Cancer. 2019-7-8

引用本文的文献

[1]
Reduced risk of lymphedema after immediate breast reconstruction in breast cancer: a retrospective nationwide study.

Sci Rep. 2025-8-5

[2]
Breast Cancer Screening in Asian Countries: Epidemiology, Screening Practices, Outcomes, Challenges, and Future Directions.

Korean J Radiol. 2025-8

[3]
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).

Breast. 2025-5-12

[4]
Disease Burden of 30 Cancer Groups in Taiwan from 2000 to 2021.

J Epidemiol Glob Health. 2025-4-22

[5]
Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers.

BMC Cancer. 2025-3-13

[6]
Treatment Patterns and Outcomes of Young Female Early Breast Cancer in Taiwan.

J Breast Cancer. 2025-2

[7]
Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer.

Ann Surg Oncol. 2025-5

[8]
Targeting Nudix Hydrolase 5 with Bioactive Flavonoids: Molecular Dynamics and Docking Studies for Breast Cancer Therapy.

Cell Biochem Biophys. 2025-6

[9]
Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance.

Exp Mol Med. 2024-11

[10]
Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study.

ESMO Open. 2024-11

本文引用的文献

[1]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018-9-12

[2]
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.

Nat Commun. 2018-4-30

[3]
Population Control Policies and Fertility Convergence.

J Econ Perspect. 2017

[4]
Surgery for early breast cancer in the extremely elderly leads to improved outcomes - An Asian population study.

Breast. 2017-9-22

[5]
Spatial distribution and ecological risk assessment of phthalic acid esters and phenols in surface sediment from urban rivers in Northeast China.

Environ Pollut. 2016-12

[6]
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013.

Cancer Res Treat. 2016-4

[7]
Global patterns and trends in colorectal cancer incidence and mortality.

Gut. 2016-1-27

[8]
World meat consumption patterns: An overview of the last fifty years (1961-2011).

Meat Sci. 2015-5-21

[9]
Female breast cancer incidence among Asian and Western populations: more similar than expected.

J Natl Cancer Inst. 2015-4-13

[10]
Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011.

Breast Cancer. 2015-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索